ABL Bio (Korea) Price on October 5, 2023
298380 Stock | KRW 27,200 300.00 1.09% |
If you're considering investing in ABL Stock, it is important to understand the factors that can impact its price. As of today, the current price of ABL Bio stands at 27,200, as last reported on the 30th of November, with the highest price reaching 28,300 and the lowest price hitting 26,900 during the day. ABL Bio secures Sharpe Ratio (or Efficiency) of -0.055, which signifies that the company had a -0.055% return per unit of return volatility over the last 3 months. ABL Bio exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ABL Bio's Standard Deviation of 4.5, variance of 20.23, and Mean Deviation of 3.54 to double-check the risk estimate we provide.
ABL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ABL |
Sharpe Ratio = -0.055
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 298380 |
Estimated Market Risk
4.59 actual daily | 40 60% of assets are more volatile |
Expected Return
-0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ABL Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABL Bio by adding ABL Bio to a well-diversified portfolio.
ABL Bio Valuation on October 5, 2023
It is possible to determine the worth of ABL Bio on a given historical date. On October 5, 2023 ABL was worth 19280.0 at the beginning of the trading date compared to the closed value of 19180.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ABL Bio stock. Still, in general, we apply an absolute valuation method to find ABL Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ABL Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ABL Bio's related companies.
Open | High | Low | Close | Volume | |
18,680 | 19,100 | 18,360 | 18,990 | 249,707 | |
10/05/2023 | 19,280 | 19,900 | 18,890 | 19,180 | 463,489 |
19,200 | 19,850 | 19,170 | 19,750 | 233,638 |
Backtest ABL Bio | | | ABL Bio History | | | ABL Bio Valuation | Previous | Next |
ABL Bio Trading Date Momentum on October 5, 2023
On October 06 2023 ABL Bio was traded for 19,750 at the closing time. The highest price during the trading period was 19,850 and the lowest recorded bid was listed for 19,170 . The volume for the day was 233.6 K. This history from October 6, 2023 contributed to the next trading day price jump. The daily price change to the next closing price was 2.97% . The overall trading delta to the current price is 2.29% . |
ABL Bio Fundamentals Correlations and Trends
By evaluating ABL Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ABL Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ABL financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ABL Bio Stock history
ABL Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ABL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ABL Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ABL Bio stock prices may prove useful in developing a viable investing in ABL Bio
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
ABL Bio Stock Technical Analysis
ABL Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ABL Bio Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
ABL Bio cannot be verified against its exchange. Please verify the symbol is currently traded on KOSDAQ. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ABL Bio November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how ABL Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ABL Bio shares will generate the highest return on investment. By undertsting and applying ABL Bio stock market strength indicators, traders can identify ABL Bio entry and exit signals to maximize returns
ABL Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ABL Bio's price direction in advance. Along with the technical and fundamental analysis of ABL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ABL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0016 | |||
Jensen Alpha | (0.13) | |||
Total Risk Alpha | (0.80) | |||
Treynor Ratio | (0.08) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |